News | Biotech giant recommits to major Wisconsin hub despite cuts across US office portfolio

FierceBiotechAs Akeso takes center stage at ASCO, China biotech industry cements its coming of age

FierceBiotechIMU Biosciences nabs $53M funding round to ‘decode’ the immune system

10x Genomics NewsDeutsche Bank Adjusts Price Target on 10x Genomics to $30 From $23, Maintains Hold Rating - marketscreener.com

FierceBiotechAscidian, Lilly ink RNA exon editing pact worth up to $1.9B for genetic kidney diseases

Endpoints NewsLilly strikes Ascidian deal worth up to $1.9B for RNA editing in kidney diseases

BioPharma DiveLilly, Ascidian link up in RNA exon editing pact

CellPlant cell wall-plasma membrane attachments mediate stress resilience through cellulose synthase complexes and remorins

CellExplosive cytotoxicity of ruptoblasts bridges hormone surveillance and immune defense

LabiotechSurge in M&As driven by patent expirations

Thermo FisherThermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate Drug Discovery - BioSpectrum Asia

eLifeHSD17B7 is required for the function of sensory hair cells by regulating cholesterol synthesis

BioPharma DiveCelcuity breast cancer drug misses ‘lofty’ expectations in ASCO-spotlighted trial